The problem
Today, we mostly use pathology to diagnose disease—not to prevent it. But the signals are
already there, in tissue we examine every day.
We are changing that
The Preventive Pathology Program is building a new model of care—one that uses
tissue-based insights to:
- Identify patients at risk before cancer develops
- Detect hereditary cancer syndromes earlier
- Guide smarter, more precise surveillance
This is a moment of opportunity
We now have the technology to digitize and analyze tissue at scale.
We have years of archived clinical data waiting to be unlocked.
We have the ability to turn everyday pathology into predictive insight.
What we need is the vision to bring it together.
Why it matters
Because the greatest opportunity in cancer care is not treating disease earlier—it is preventing
it altogether. Pathology sits at the center of that transformation.
Focus areas
- Gastrointestinal precancer & early neoplasia
- Hereditary cancer syndromes (Lynch syndrome detection)
- Breast & gynecologic precursor lesions
- AI-based biomarker discovery from routine histology
Join us
Help lead a shift in medicine—from reacting to disease to stopping it before it begins. We welcome partners across clinical, computational, and translational domains.
Contact: Monika Vyas, MD, Director, Digital Pathology, BIDMC, [contact info]
